Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bb7e5a8353928ba3c6be979dccdd54270> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bb7e5a8353928ba3c6be979dccdd54270 NCIT_P378 "NCI" @default.
- Bb7e5a8353928ba3c6be979dccdd54270 type Axiom @default.
- Bb7e5a8353928ba3c6be979dccdd54270 annotatedProperty IAO_0000115 @default.
- Bb7e5a8353928ba3c6be979dccdd54270 annotatedSource NCIT_C173001 @default.
- Bb7e5a8353928ba3c6be979dccdd54270 annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with trastuzumab and pertuzumab in patients with cancers that have ERBB2 (HER2) amplifications, excluding breast cancers, colorectal cancers, gastric cancers and gastroesophageal junction (GEJ) cancers." @default.